Evolution of Pap Stain

Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain ha...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Raju, Kalyani [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2016

Schlagwörter:	Cervical cancer screening conventional Pap stain Cytocolor Enviro-Pap stain Pap stain Rapid Pap stain REAP stain

Anmerkung:	© Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016

Übergeordnetes Werk:	Enthalten in: Biomedical research and therapy - Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014, 3(2016), 2 vom: 25. Feb.
Übergeordnetes Werk:	volume:3 ; year:2016 ; number:2 ; day:25 ; month:02

Links:	Volltext

DOI / URN:	10.7603/s40730-016-0006-8

Katalog-ID:	SPR038082381

Internformat


LEADER	01000caa a22002652 4500
001	SPR038082381
003	DE-627
005	20230519145209.0
007	cr uuu---uuuuu
008	201007s2016 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.7603/s40730-016-0006-8 \|2 doi
035			\|a (DE-627)SPR038082381
035			\|a (SPR)s40730-016-0006-8-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	1		\|a Raju, Kalyani \|e verfasserin \|4 aut
245	1	0	\|a Evolution of Pap Stain
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016
520			\|a Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique.
650		4	\|a Cervical cancer screening \|7 (dpeaa)DE-He213
650		4	\|a conventional Pap stain \|7 (dpeaa)DE-He213
650		4	\|a Cytocolor \|7 (dpeaa)DE-He213
650		4	\|a Enviro-Pap stain \|7 (dpeaa)DE-He213
650		4	\|a Pap stain \|7 (dpeaa)DE-He213
650		4	\|a Rapid Pap stain \|7 (dpeaa)DE-He213
650		4	\|a REAP stain \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Biomedical research and therapy \|d Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014 \|g 3(2016), 2 vom: 25. Feb. \|w (DE-627)815915594 \|w (DE-600)2806789-7 \|x 2198-4093 \|7 nnns
773	1	8	\|g volume:3 \|g year:2016 \|g number:2 \|g day:25 \|g month:02
856	4	0	\|u https://dx.doi.org/10.7603/s40730-016-0006-8 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 3 \|j 2016 \|e 2 \|b 25 \|c 02

Indexfelder

author_variant	k r kr
matchkey_str	article:21984093:2016----::vltoop
hierarchy_sort_str	2016
publishDate	2016
allfields	10.7603/s40730-016-0006-8 doi (DE-627)SPR038082381 (SPR)s40730-016-0006-8-e DE-627 ger DE-627 rakwb eng Raju, Kalyani verfasserin aut Evolution of Pap Stain 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016 Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. Cervical cancer screening (dpeaa)DE-He213 conventional Pap stain (dpeaa)DE-He213 Cytocolor (dpeaa)DE-He213 Enviro-Pap stain (dpeaa)DE-He213 Pap stain (dpeaa)DE-He213 Rapid Pap stain (dpeaa)DE-He213 REAP stain (dpeaa)DE-He213 Enthalten in Biomedical research and therapy Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014 3(2016), 2 vom: 25. Feb. (DE-627)815915594 (DE-600)2806789-7 2198-4093 nnns volume:3 year:2016 number:2 day:25 month:02 https://dx.doi.org/10.7603/s40730-016-0006-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2016 2 25 02
spelling	10.7603/s40730-016-0006-8 doi (DE-627)SPR038082381 (SPR)s40730-016-0006-8-e DE-627 ger DE-627 rakwb eng Raju, Kalyani verfasserin aut Evolution of Pap Stain 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016 Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. Cervical cancer screening (dpeaa)DE-He213 conventional Pap stain (dpeaa)DE-He213 Cytocolor (dpeaa)DE-He213 Enviro-Pap stain (dpeaa)DE-He213 Pap stain (dpeaa)DE-He213 Rapid Pap stain (dpeaa)DE-He213 REAP stain (dpeaa)DE-He213 Enthalten in Biomedical research and therapy Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014 3(2016), 2 vom: 25. Feb. (DE-627)815915594 (DE-600)2806789-7 2198-4093 nnns volume:3 year:2016 number:2 day:25 month:02 https://dx.doi.org/10.7603/s40730-016-0006-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2016 2 25 02
allfields_unstemmed	10.7603/s40730-016-0006-8 doi (DE-627)SPR038082381 (SPR)s40730-016-0006-8-e DE-627 ger DE-627 rakwb eng Raju, Kalyani verfasserin aut Evolution of Pap Stain 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016 Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. Cervical cancer screening (dpeaa)DE-He213 conventional Pap stain (dpeaa)DE-He213 Cytocolor (dpeaa)DE-He213 Enviro-Pap stain (dpeaa)DE-He213 Pap stain (dpeaa)DE-He213 Rapid Pap stain (dpeaa)DE-He213 REAP stain (dpeaa)DE-He213 Enthalten in Biomedical research and therapy Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014 3(2016), 2 vom: 25. Feb. (DE-627)815915594 (DE-600)2806789-7 2198-4093 nnns volume:3 year:2016 number:2 day:25 month:02 https://dx.doi.org/10.7603/s40730-016-0006-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2016 2 25 02
allfieldsGer	10.7603/s40730-016-0006-8 doi (DE-627)SPR038082381 (SPR)s40730-016-0006-8-e DE-627 ger DE-627 rakwb eng Raju, Kalyani verfasserin aut Evolution of Pap Stain 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016 Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. Cervical cancer screening (dpeaa)DE-He213 conventional Pap stain (dpeaa)DE-He213 Cytocolor (dpeaa)DE-He213 Enviro-Pap stain (dpeaa)DE-He213 Pap stain (dpeaa)DE-He213 Rapid Pap stain (dpeaa)DE-He213 REAP stain (dpeaa)DE-He213 Enthalten in Biomedical research and therapy Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014 3(2016), 2 vom: 25. Feb. (DE-627)815915594 (DE-600)2806789-7 2198-4093 nnns volume:3 year:2016 number:2 day:25 month:02 https://dx.doi.org/10.7603/s40730-016-0006-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2016 2 25 02
allfieldsSound	10.7603/s40730-016-0006-8 doi (DE-627)SPR038082381 (SPR)s40730-016-0006-8-e DE-627 ger DE-627 rakwb eng Raju, Kalyani verfasserin aut Evolution of Pap Stain 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016 Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. Cervical cancer screening (dpeaa)DE-He213 conventional Pap stain (dpeaa)DE-He213 Cytocolor (dpeaa)DE-He213 Enviro-Pap stain (dpeaa)DE-He213 Pap stain (dpeaa)DE-He213 Rapid Pap stain (dpeaa)DE-He213 REAP stain (dpeaa)DE-He213 Enthalten in Biomedical research and therapy Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014 3(2016), 2 vom: 25. Feb. (DE-627)815915594 (DE-600)2806789-7 2198-4093 nnns volume:3 year:2016 number:2 day:25 month:02 https://dx.doi.org/10.7603/s40730-016-0006-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2016 2 25 02
language	English
source	Enthalten in Biomedical research and therapy 3(2016), 2 vom: 25. Feb. volume:3 year:2016 number:2 day:25 month:02
sourceStr	Enthalten in Biomedical research and therapy 3(2016), 2 vom: 25. Feb. volume:3 year:2016 number:2 day:25 month:02
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Cervical cancer screening conventional Pap stain Cytocolor Enviro-Pap stain Pap stain Rapid Pap stain REAP stain
isfreeaccess_bool	false
container_title	Biomedical research and therapy
authorswithroles_txt_mv	Raju, Kalyani @@aut@@
publishDateDaySort_date	2016-02-25T00:00:00Z
hierarchy_top_id	815915594
id	SPR038082381
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR038082381</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519145209.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7603/s40730-016-0006-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR038082381</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s40730-016-0006-8-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Raju, Kalyani</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evolution of Pap Stain</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cervical cancer screening</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">conventional Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cytocolor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enviro-Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rapid Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">REAP stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Biomedical research and therapy</subfield><subfield code="d">Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014</subfield><subfield code="g">3(2016), 2 vom: 25. Feb.</subfield><subfield code="w">(DE-627)815915594</subfield><subfield code="w">(DE-600)2806789-7</subfield><subfield code="x">2198-4093</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">day:25</subfield><subfield code="g">month:02</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.7603/s40730-016-0006-8</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="b">25</subfield><subfield code="c">02</subfield></datafield></record></collection>
author	Raju, Kalyani
spellingShingle	Raju, Kalyani misc Cervical cancer screening misc conventional Pap stain misc Cytocolor misc Enviro-Pap stain misc Pap stain misc Rapid Pap stain misc REAP stain Evolution of Pap Stain
authorStr	Raju, Kalyani
ppnlink_with_tag_str_mv	@@773@@(DE-627)815915594
format	electronic Article
delete_txt_mv	keep
author_role	aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2198-4093
topic_title	Evolution of Pap Stain Cervical cancer screening (dpeaa)DE-He213 conventional Pap stain (dpeaa)DE-He213 Cytocolor (dpeaa)DE-He213 Enviro-Pap stain (dpeaa)DE-He213 Pap stain (dpeaa)DE-He213 Rapid Pap stain (dpeaa)DE-He213 REAP stain (dpeaa)DE-He213
topic	misc Cervical cancer screening misc conventional Pap stain misc Cytocolor misc Enviro-Pap stain misc Pap stain misc Rapid Pap stain misc REAP stain
topic_unstemmed	misc Cervical cancer screening misc conventional Pap stain misc Cytocolor misc Enviro-Pap stain misc Pap stain misc Rapid Pap stain misc REAP stain
topic_browse	misc Cervical cancer screening misc conventional Pap stain misc Cytocolor misc Enviro-Pap stain misc Pap stain misc Rapid Pap stain misc REAP stain
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Biomedical research and therapy
hierarchy_parent_id	815915594
hierarchy_top_title	Biomedical research and therapy
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)815915594 (DE-600)2806789-7
title	Evolution of Pap Stain
ctrlnum	(DE-627)SPR038082381 (SPR)s40730-016-0006-8-e
title_full	Evolution of Pap Stain
author_sort	Raju, Kalyani
journal	Biomedical research and therapy
journalStr	Biomedical research and therapy
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2016
contenttype_str_mv	txt
author_browse	Raju, Kalyani
container_volume	3
format_se	Elektronische Aufsätze
author-letter	Raju, Kalyani
doi_str_mv	10.7603/s40730-016-0006-8
title_sort	evolution of pap stain
title_auth	Evolution of Pap Stain
abstract	Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016
abstractGer	Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016
abstract_unstemmed	Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique. © Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	2
title_short	Evolution of Pap Stain
url	https://dx.doi.org/10.7603/s40730-016-0006-8
remote_bool	true
ppnlink	815915594
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.7603/s40730-016-0006-8
up_date	2024-07-03T16:07:23.314Z
_version_	1803574672948723712
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR038082381</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519145209.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7603/s40730-016-0006-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR038082381</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s40730-016-0006-8-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Raju, Kalyani</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evolution of Pap Stain</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Laboratory of Stem Cell Research and Application, HCMUS, VNU-HCM 2016</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Pap stain was first developed by Dr GN Papanicoloau in 1947 and since then it has been used successfully to screen cervical cancer. In fact, it has reduced the incidence of cervical cancer by 70% especially in developed countries having well planned screening programs. However, the stain has undergone various modifications from regressive conventional method to progressive rapid Pap staining where the time taken for staining was reduced. Further the stain was modified as ultrafast Papanocoloau stain and modified ultrafast Pap stain were air dried cervical smears were used and staining time was reduced. Later the other modifications were Enviro- Pap stain which was environmentally friendly with results similar to conventional method; REAP stain which was rapid and economical and Cytocolor developed by Merck where isopropyl alcohol is replaced by Propanol. Each method has advantages and disadvantages. Hence laboratories should develop their own protocol and standardize the staining technique.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cervical cancer screening</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">conventional Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cytocolor</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enviro-Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rapid Pap stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">REAP stain</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Biomedical research and therapy</subfield><subfield code="d">Ho Chi Minh city : Laboratory of Stem Cell Research and Application, 2014</subfield><subfield code="g">3(2016), 2 vom: 25. Feb.</subfield><subfield code="w">(DE-627)815915594</subfield><subfield code="w">(DE-600)2806789-7</subfield><subfield code="x">2198-4093</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:2</subfield><subfield code="g">day:25</subfield><subfield code="g">month:02</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.7603/s40730-016-0006-8</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2016</subfield><subfield code="e">2</subfield><subfield code="b">25</subfield><subfield code="c">02</subfield></datafield></record></collection>
score	7.401143

Nicht das Richtige dabei?

Schreiben Sie uns!

Evolution of Pap Stain

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?